A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
Status:
Terminated
Trial end date:
2020-07-08
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of relamorelin compared to placebo in
participants with diabetic gastroparesis. Participants will report daily severity scores of
their diabetic gastroparesis symptoms.